Management strategies for rising pharmaceutical expenditures

P and T

Volumn 26, Issue 3, 2001, Pages 140-148

  Oinonen, M ^a   Shah, N ^a   Vermeulen, L ^a   Palmer, M ^a   Matuszewski, K ^a  

^a University HealthSystem Consortium ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; PATIENT CARE; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW;

EID: 0035085817     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. The next decade of health spending: A new outlook. The National Health Expenditures Projection Team
2. 1998 IMS HEALTH hospital pharmacy review: Leading dollar volume pharmaceuticals
3. Intended and unintended consequences of HMO cost-containment strategies: Results from the Managed Care Outcomes Project
4. Pharmaceutical cost containment and innovation in the United States
5. Experience with a two-tiered therapeutic interchange policy
6. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine
7. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital
8. Therapeutic-interchange program for oral histamine H2-receptor antagonists
9. Impact of therapeutic interchange from pravastatin to lovastatin in a veterans affairs medical center
10. ASHP national survey of pharmacy practice in acute care settings: Prescribing and transcribing - 1998
11. Strategies for therapeutic interchange of biotechnology medicines: Proceedings of an invitational conference
12. Prevention of venous thromboembolism
13. Prevention of venous thromboembolism
14. Prevention of venous thromboembolism: Adherence to the 1995 American College of Chest Physicians Consensus guidelines for surgical patients
15. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making
16. Economic evaluations of clinical pharmacy services - 1988-1995. The Publications Committee of the American College of Clinical Pharmacy
17. Clinical pharmacy services and hospital mortality rates
18. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
19. Re-engineering: An opportunity to advance clinical practice in a community hospital
20. Cost benefit of sumatriptan to an employer
21. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
22. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment
23. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy
24. Trends in collaborative drug therapy management
25. North Carolina, Louisiana legislate collaborative drug therapy management
26. Pharmacist prescriptive authority in the ambulatory oncology clinic
27. Pharmacist prescribing: Harborview Medical Center
28. Pharmacist management of a hyperlipidemia clinic
29. Management of acute and chronic pain
30. Outpatient psychiatric prescriptive authority
31. Home and hospice care
32. Immunization and the pharmacist
33. Pharmaceutical care services and results in project IMPACT: Hyperlipidemia
34. Pharmacy database for tracking drug costs and utilization
35. Projecting future drug expenditures - 1999
36. Projecting future drug expenditures - 2000
37. Costs and savings of investigational drug services
38. Epoetin alfa for dialysis outpatients: Analysis of administered versus Medicare-reimbursed units
39. Improving the process of medication budget forecasting